- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Prothrombin Complex Concentrate for Rapid Preoperative Reversal of Warfarin-Related Coagulopatby in Patients with Diffuse Peritonitis: Two Cases Report
-
- Kojika Masahiro
- Department of Critical Care Medicine, Iwate Medical University
-
- Sato Nobuhiro
- Department of Critical Care Medicine, Iwate Medical University
-
- Suzuki Yasushi
- Department of Critical Care Medicine, Iwate Medical University
-
- Yoshida Yuki
- Department of Critical Care Medicine, Iwate Medical University
-
- Inoue Yoshihiro
- Department of Critical Care Medicine, Iwate Medical University
-
- Wakabayashi Go
- Department of Surgery I, Iwate Medical University
-
- Endo Shigeatsu
- Department of Critical Care Medicine, Iwate Medical University
Bibliographic Information
- Other Title
-
- ワーファリン内服中の腹膜炎緊急手術時に乾燥人血液凝固第IX因子複合体を術前投与した2例
Search this article
Description
Emergency surgeries were conducted with the aid of a mixed type coagulation factor preparation on 2 patients who developed peritonitis while under oral medication with warfarin. The first case, an 80-year-male, had been treated with 2mg/day of oral warfarin following aortic valvoplasty and prosthetic vascular replacement. He underwent surgery for perforating appendicitis and peritoneal abscess. Prior to the surgical procedure, his PT (INR) was 4.69 and Thrombotest, below 5%. The second case, an 89-year-old woman, had been treated with 1.5mg/day of oral warfarin for atrial fibrillation. She underwent surgery with a diagnosis of strangulating ileus. Her preoperative PT (INR) was 2.73 and Thrombotest, 5.2%. To these two patients, 500E of a prothrombin complex concentrates (PCC) was administered prior to surgery. The coagulation test that was conducted on these patients 15 minutes after this treatment showed a marked shortening in the coagulation time in the PT (INR) and Thrombotest. Their pen-operative courses were uneventful, without hemorrhagic tendencies or complications. The use of a mixed coagulation factor preparation is not included in the current coverage under our National Health Insurance Policy when it is applied to patients who had been receiving warfarin and undergoing emergency surgery. However, the efficacy of the preparation was indicated in these cases. An evaluation is needed to see if the current coverage under this insurance policy should be extended to include this modification.
Journal
-
- Nihon Kyukyu Igakukai Zasshi
-
Nihon Kyukyu Igakukai Zasshi 16 (10), 581-586, 2005
Japanese Association for Acute Medicine
- Tweet
Details 詳細情報について
-
- CRID
- 1390001204368745344
-
- NII Article ID
- 130003625979
- 10020547936
-
- NII Book ID
- AN10284604
-
- ISSN
- 18833772
- 0915924X
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- Crossref
- CiNii Articles
- OpenAIRE
-
- Abstract License Flag
- Disallowed